297 related articles for article (PubMed ID: 1926047)
1. Progress in the clinical management of haemophilia.
Bloom AL
Thromb Haemost; 1991 Jul; 66(1):166-77. PubMed ID: 1926047
[No Abstract] [Full Text] [Related]
2. Hepatitis C and pasteurised factor VIII and IX concentrates.
Klarmann D; Kreuz W; Auerswald G; Auberger K; Rabenau H; Gürtler L; Roggendorf M
Thromb Haemost; 1995 Apr; 73(4):736-7. PubMed ID: 7495095
[No Abstract] [Full Text] [Related]
3. Blood and neoplastic diseases. Haemophilia and related disorders.
Rizza CR
Br Med J; 1974 Oct; 4(5935):36-8. PubMed ID: 4547674
[No Abstract] [Full Text] [Related]
4. Prevention of hepatitis C virus infection in children with haemophilia A and B and von Willebrand's disease.
Kreuz W; Auerswald G; Brückmann C; Zieger B; Linde R; Funk M; Auberger K; Sutor AH; Rasshofer R; Roggendorf M
Thromb Haemost; 1992 Jan; 67(1):184. PubMed ID: 1615476
[No Abstract] [Full Text] [Related]
5. Clinical and biological survey of haemophilia A and B patients infused with French heat-treated concentrates.
Parquet A; Boneu B; Bosser C; Cazenave JP; Dirat G; Gazengel G; Grunebaum L; Sultan Y; Verroust F; Wiesel ML
Nouv Rev Fr Hematol (1978); 1988; 30(4):205-7. PubMed ID: 3143099
[TBL] [Abstract][Full Text] [Related]
6. [The treatment of inherited coagulation disorders].
Blombäck M; Nilsson IM
Lakartidningen; 1972 Dec; 69():Suppl 4:76-84. PubMed ID: 4540328
[No Abstract] [Full Text] [Related]
7. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography.
Sultan Y; Boyeldieu D; Stieltjes N
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S59-60. PubMed ID: 8177717
[TBL] [Abstract][Full Text] [Related]
8. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
Hedner U
Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
[No Abstract] [Full Text] [Related]
9. From the Centers for Disease Control and Prevention. Hepatitis A among persons with hemophilia who received clotting factor concentrate--United States, September-December 1995.
JAMA; 1996 Feb; 275(6):427-8. PubMed ID: 8627951
[No Abstract] [Full Text] [Related]
10. Immunologic studies in asymptomatic hemophiliac patients.
Frydecka I; Kowalewska B; Lesiecki A; Kuliczkowski K; Palakowska A; Polkowski A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):708-15. PubMed ID: 2435638
[TBL] [Abstract][Full Text] [Related]
11. Switching haemophilia products and inhibitor risk: a United States' perspective.
Nance D; Rodgers GM
Eur J Haematol; 2015 Apr; 94(4):283. PubMed ID: 25800968
[No Abstract] [Full Text] [Related]
12. A comparison of coagulation factor replacement with and without prednisolone in the treatment of haematuria in haemophilia and Christmas disease.
Rizza CR; Kernoff PB; Matthews JM; McLennan CR; Rainsford SG
Thromb Haemost; 1977 Feb; 37(1):86-90. PubMed ID: 320712
[TBL] [Abstract][Full Text] [Related]
13. Surgical care of patients with hereditary disorders of blood coagulation.
Shulman NR
Mod Treat; 1968 Jan; 5(1):61-83. PubMed ID: 4870180
[No Abstract] [Full Text] [Related]
14. Hepatitis A among persons with hemophilia who received clotting factor concentrate--United States, September-December 1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1996 Jan; 45(2):29-32. PubMed ID: 8531917
[TBL] [Abstract][Full Text] [Related]
15. Medical staff conference: Hemophilia and von Willebrand's disease. Fourth annual Paul M. Aggeler memorial lecture.
West J Med; 1974 Mar; 120(3):226-32. PubMed ID: 4544608
[No Abstract] [Full Text] [Related]
16. Viral safety of plasma-derived factor VIII and IX concentrates.
Ludlam CA
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S19-23. PubMed ID: 9351532
[TBL] [Abstract][Full Text] [Related]
17. How to manage invasive procedures in children with haemophilia.
Ljung RC; Knobe K
Br J Haematol; 2012 Jun; 157(5):519-28. PubMed ID: 22390160
[TBL] [Abstract][Full Text] [Related]
18. Concentrated preparations of Factor 8 (antihaemophilic globulin) in the management of haemophilia A and von Willebrand's disease.
Castaldi PA; Somer JB; Schiff P; Blackburn CR
Med J Aust; 1967 Sep; 2(11):481-5. PubMed ID: 5299300
[No Abstract] [Full Text] [Related]
19. [A new therapy of hemophilia with ranitidine].
Hu LM; Ye LL; Xu B
Zhonghua Nei Ke Za Zhi; 1990 Feb; 29(2):85-7, 125. PubMed ID: 2120016
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis in children with hemophilia: is it the optimal treatment?
Lusher JM
Thromb Haemost; 1997 Jul; 78(1):726-9. PubMed ID: 9198246
[No Abstract] [Full Text] [Related]
[Next] [New Search]
